Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant


Talaris Therapeutics is a late-clinical stage cell therapy company that is developing an innovative method of allogeneic stem cell transplantation that we believe has the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe non-malignant blood, immune and metabolic disorders. In the organ transplant setting, which is our initial focus, we believe that our proprietary therapeutic approach could prevent organ rejection without the consequences associated with the use of chronic immunosuppression.

FCR001 in Transplantation

How does FCR001 work?


Connect with us

medicalinformation@talaristx.com

Follow us!

© 2022 TTS 2022